Morgan Stanley sets $40 target on Kyverna Therapeutics shares By Investing.com
© Reuters. On Monday, Morgan Stanley initiated protection on Kyverna Therapeutics Inc (NASDAQ:KYTX), a biopharmaceutical firm, with an Chubby ranking ...
Tag: Therapeutics
Astria Therapeutics: Too Much Risk, Little Reward Despite Near-Term Data Readout (ATXS)
Dilok KlaisatapornFunding Overview The biotech business could be a powerful enterprise to be in, however traders favour the sector, pouring ...
Dutch-based Orexa raises €870K to develop therapeutics to increase food intake | Silicon Canals
Herpen, the Netherlands-based Orexa, a clinical-stage pharmaceutical firm, introduced on Wednesday, January 31, that it has secured €870K from new ...
4D Molecular Therapeutics (FDMT): Several Catalysts To Watch in 2024
Михаил Руденко/iStock through Getty Photographs 4D Molecular Therapeutics (NASDAQ:FDMT) has a number of scientific applications in its pipeline, with one ...
Citigroup upgrades Larimar Therapeutics to Buy, predicts 284% surge By Investing.com
© Reuters. NEW YORK - Citigroup has revised its stance on Larimar Therapeutics (NASDAQ: LRMR), upgrading the inventory from Impartial ...
Amsterdam’s VectorY Therapeutics closes one of Europe’s largest private biotech financings in 2023 | Silicon Canals
Picture credit: VectorY Therapeutics Amsterdam-based VectorY Therapeutics, a biotech firm, introduced on Monday that it has secured €129M in a ...
Stocks making the biggest moves midday: Rivian, Orchard Therapeutics, Lamb Weston and more
McDonald's french fries being ready.Daniel Acker | Bloomberg | Getty PhotosTake a look at the businesses making headlines in noon ...
Biggest stock movers today: KE Holdings, Pliant Therapeutics and more
Inventory futures edged down within the early hours of Tuesday, forward of necessary financial information releases later within the day. ...
SpringWorks Therapeutics gets new chief scientific officer (NASDAQ:SWTX)
Medical-stage biopharmaceutical firm SpringWorks Therapeutics (NASDAQ:SWTX) appoints Dr. Tai-An Lin, Ph.D., as its Chief Scientific Officer. Dr. Lin brings greater than 25 years ...
Autolus Therapeutics: Innovating T Cell Cancer Treatments (NASDAQ:AUTL)
CIPhotos Introduction Autolus Therapeutics (NASDAQ:AUTL) is a number one biopharmaceutical agency innovating T cell therapies for most cancers therapy. They've ...
